
Fortrea Holdings Investor Relations Material
Latest events

Q2 2025
Fortrea Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fortrea Holdings Inc
Access all reports
Fortrea Holdings Inc. is a global contract research organization that specializes in supporting the development of biopharmaceutical products and medical devices across all phases of the clinical trial process. It offers a broad range of services, including clinical pharmacology, patient access solutions, and other enabling services. The company's operations are divided into two main segments: Clinical Services and Enabling Services. The Clinical Services segment covers the entire spectrum of clinical development, while the Enabling Services segment focuses on facilitating patient access and optimizing clinical trial technologies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Key slides for Fortrea Holdings Inc


Q2 2025
Fortrea Holdings Inc


Q1 2025
Fortrea Holdings Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
FTRE
Country
🇺🇸 United States